Pildralazine

This classification denotes a vasodilating agent with the molecular formula C8H15N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FU2BGC781U, chemically known as 3(2h)-pyridazinone, 6-((2-hydroxypropyl)methylamino)-, hydrazone but generally known as pildralazine, which bears US NIH Compound Identifier 68829. European Medicines Agency schedules Pildralazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09833MIG. The term PILDRALAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). PILDRALAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pildralazine under HS 29339990 and SITC 51577. As of Q4 2014, PILDRALAZINE remains the US FDA Preferred Term for this commodity. Pildralazine bears US NLM identifiers UMLS ID C0072178 and NCI Concept Code C66383. SMILES: OC(CN(c1nnc(NN)cc1)C)C.